1. Home
  2. Analysis
  3. Jardiance
  4. Edarbyclor

Jardiance and Edarbyclor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Jardiance and Edarbyclor. Common interactions include anaemia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people who take Jardiance and Edarbyclor have. It is created by eHealthMe based on reports of 9 people who take Jardiance and Edarbyclor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 05, 2023

9 people who take Jardiance and Edarbyclor together, and have interactions are studied.

What is Jardiance?

Jardiance has active ingredients of empagliflozin. eHealthMe is studying from 29,064 Jardiance users for its effectiveness, alternative drugs and more.

What is Edarbyclor?

Edarbyclor has active ingredients of azilsartan kamedoxomil; chlorthalidone. It is often used in high blood pressure. eHealthMe is studying from 1,265 Edarbyclor users for its effectiveness, alternative drugs and more.

Number of Jardiance and Edarbyclor reports submitted per year:

Jardiance and Edarbyclor drug interactions.

Common Jardiance and Edarbyclor drug interactions by gender *:

female:

  1. Anaemia
  2. Chronic kidney disease
  3. Constipation
  4. Hypothyroidism
  5. Pain in extremity
  6. Pre-existing condition improved
  7. Vitamin d deficiency

male:

  1. Asthenia
  2. Erythema
  3. Weight decreased
  4. Hypotension
  5. Myocardial infarction
  6. Oedema
  7. Perineal abscess
  8. Sepsis
  9. Septic shock
  10. Staphylococcal bacteraemia

Common Jardiance and Edarbyclor drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Asthenia
  2. Constipation
  3. Staphylococcal bacteraemia
  4. Therapeutic response unexpected
  5. Weight decreased
  6. Erythema
  7. Hypotension
  8. Myocardial infarction
  9. Oedema
  10. Pain in extremity

* Approximation only. Some reports may have incomplete information.

Do you take Jardiance and Edarbyclor?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Jardiance and Edarbyclor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Jardiance side effects:

Browse all side effects of Jardiance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Edarbyclor side effects:

Browse all side effects of Edarbyclor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Jardiance interactions:

Browse all interactions between Jardiance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Edarbyclor interactions:

Browse all interactions between Edarbyclor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on empagliflozin and azilsartan kamedoxomil; chlorthalidone (the active ingredients of Jardiance and Edarbyclor, respectively), and Jardiance and Edarbyclor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Jardiance and Edarbyclor.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.